Telocyte
Michael Fossel has an extensive background in medicine and academia. Michael has held various positions in different companies, focusing on areas such as physician consulting, teaching, and research. Currently, Michael is the President of Telocyte, a company working on developing telomerase therapy for Alzheimer's disease. In the past, Michael has also served as an Editor in Chief for OBM Geriatrics and held positions at Cerner Corporation and Trinity Health. Michael holds degrees in Medicine, Neurobiology, and Psychology from Stanford University and Wesleyan University.
This person is not in the org chart
This person is not in any teams
Telocyte
We are a biotechnology company dedicated to curing Alzheimer's disease. We are planning FDA-sponsored human trials, using telomerase therapy to reset cell aging within the central nervous system. We believe that Alzheimer's disease can stopped, prevented, and cured.